Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Highlights
ABT's P/E is 39% above its last 4 quarters average of 44.6 but 13% below its 5-year quarterly average of 71.3
The EPS has contracted by 13% from the previous quarter but it has grown by 7% YoY
Abbott Laboratories's debt has increased by 8% QoQ and by 2.5% YoY
ABT's equity is down by 3.4% year-on-year
Key stats
What are the main financial stats of ABT
Market
Shares outstanding
1.77B
Market cap
$192.69B
Enterprise value
$207.6B
Valuations
Price to earnings (P/E)
62.19
Price to book (P/B)
6.25
Price to sales (P/S)
6.14
EV/EBIT
50.32
EV/EBITDA
28.48
EV/Sales
6.6
Earnings
Revenue
$31.44B
EBIT
$4.13B
EBITDA
$7.29B
Free cash flow
$4.56B
Per share
EPS
$1.75
Free cash flow per share
$2.57
Book value per share
$17.41
Revenue per share
$17.74
TBVPS
$16.87
Balance sheet
Total assets
$68.78B
Total liabilities
$37.98B
Debt
$19.68B
Equity
$30.8B
Working capital
$6.26B
Liquidity
Debt to equity
0.64
Current ratio
1.57
Quick ratio
0.93
Net debt/EBITDA
2.05
Margins
EBITDA margin
23.2%
Gross margin
57.6%
Net margin
9.9%
Operating margin
12.8%
Efficiency
Return on assets
4.6%
Return on equity
10%
Return on invested capital
12.8%
Return on capital employed
7.1%
Return on sales
13.1%
Dividend
Dividend yield
1.29%
DPS
$1.4
Payout ratio
80%
ABT stock price
How has the Abbott Laboratories stock price performed over time
Financial performance
How have Abbott Laboratories's revenue and profit performed over time
Revenue
$31.44B
Gross profit
$18.11B
Operating income
$4.02B
Net income
$3.11B
Gross margin
57.6%
Net margin
9.9%
Abbott Laboratories's net income has decreased by 13% QoQ but it has increased by 7% YoY
The operating income has contracted by 12% from the previous quarter and by 2.1% YoY
Abbott Laboratories's net margin has decreased by 12% QoQ but it has increased by 5% YoY
Abbott Laboratories's operating margin has decreased by 10% from the previous quarter and by 3.8% YoY
Growth
What is Abbott Laboratories's growth rate over time
Valuation
What is Abbott Laboratories stock price valuation
P/E
62.19
P/B
6.25
P/S
6.14
EV/EBIT
50.32
EV/EBITDA
28.48
EV/Sales
6.6
ABT's P/E is 39% above its last 4 quarters average of 44.6 but 13% below its 5-year quarterly average of 71.3
The EPS has contracted by 13% from the previous quarter but it has grown by 7% YoY
ABT's price to book (P/B) is 74% higher than its 5-year quarterly average of 3.6 and 30% higher than its last 4 quarters average of 4.8
ABT's equity is down by 3.4% year-on-year
ABT's P/S is 57% above its 5-year quarterly average of 3.9 and 28% above its last 4 quarters average of 4.8
The revenue has contracted by 2% from the previous quarter
Efficiency
How efficient is Abbott Laboratories business performance
Abbott Laboratories's return on assets has decreased by 13% QoQ but it has increased by 10% YoY
The ROIC has contracted by 13% from the previous quarter
ABT's ROE is down by 12% from the previous quarter but it is up by 8% YoY
The ROS has contracted by 12% from the previous quarter and by 2.2% YoY
Dividends
What is ABT's dividend history
DPS
$1.4
Dividend yield
1.29%
Payout ratio
80%
Recent dividends
Financial health
How did Abbott Laboratories financials performed over time
The total assets is 81% more than the total liabilities
ABT's quick ratio is up by 12% since the previous quarter but it is down by 5% year-on-year
The current ratio has increased by 10% QoQ but it has decreased by 7% YoY
Abbott Laboratories's debt is 36% lower than its equity
Abbott Laboratories's debt has increased by 8% QoQ and by 2.5% YoY
Abbott Laboratories's debt to equity has increased by 7% from the previous quarter and by 7% YoY
All financial data is based on trailing twelve months (TTM) periods - updated
quarterly, unless otherwise specified.